Document is current

Article History

Received: 20 September 2024

Revised: 26 November 2024

Accepted: 20 December 2024

First Online: 28 January 2025

Declarations

:

: Prescription data were anonymized prior to data extraction. Permission was obtained by the Ministry of Health, in accordance with the national legislation on the Protection of Individuals with regards to the Processing of Personal Data and with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: EL: Research grant to Aristotle University, Thessaloniki by Leo Pharma for the present study. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, participation on a Data Safety Monitoring Board or Advisory Board, and support for attending meetings and/or travel from Abbvie, Novartis, Pfizer, UCB, Lilly, Sanofi, Genesis Pharma, Amgen, Janssen, Galderma, Galenica, Leo Pharma. ZA: Honoraria for lectures and for travels from Abbvie, Sanofi, Pfizer, Leo, Janssen, UCB. SR: employee of ECONCARE LP which had contracts with UCB, Abbvie, Leo, BMS. GS: employee of ECONCARE LP which had contracts with UCB, Abbvie, Leo, BMS. Payments from Aristotle University, Thessaloniki for this work. Contract with Pfizer via University of the Peloponnese for therapeutic area other than psoriasis. KV: employee of ECONCARE LP which had contracts with UCB, Abbvie, Leo, BMS. AT: None. KM: None. GK: Payments from Aristotle University, Thessaloniki for this work. Contract with Pfizer via University of the Peloponnese for therapeutic area other than psoriasis. Contracts with UCB, Abbvie, Leo, BMS via consulting firm.